AlphaFold predicted structure
CFHR1 · Q03591

Mean pLDDT
89.1/ 100
Confident
330 residues
Confidence breakdown
- Very high(≥ 90)73%
- Confident(70–90)19%
- Low(50–70)2%
- Very low(< 50)5%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
complement factor H related 1
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
Atypical haemolytic uraemic syndrome
BOTH monoallelic and biallelic, autosomal or pseudoautosomalCOVID-19 research
BOTH monoallelic and biallelic, autosomal or pseudoautosomalMembranoproliferative glomerulonephritis including C3 glomerulopathy
BOTH monoallelic and biallelic, autosomal or pseudoautosomalPrimary immunodeficiency or monogenic inflammatory bowel disease
BOTH monoallelic and biallelic, autosomal or pseudoautosomalcomplement 3 glomerulopathy
age-related macular degeneration
C3 glomerulonephritis
dense deposit disease
complement deficiency
atypical hemolytic-uremic syndrome with I factor anomaly
degeneration of macula and posterior pole
macular degeneration
COVID-19
chronic kidney disease
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Complement factor H-related protein 1
Involved in complement regulation. The dimerized forms have avidity for tissue-bound complement fragments and efficiently compete with the physiological complement inhibitor CFH. Can associate with lipoproteins and may play a role in lipid metabolism
CFHR1 · Q03591

Mean pLDDT
89.1/ 100
Confident
330 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0